Yahoo Web Search

Search results

1. • 

     Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly

     Fortune via Yahoo Finance· 15 hours ago

     Good morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...

2. • Feds plan for smoother access to RSV infant shot

     Politico· 9 hours ago

     The government has repeatedly met with vaccine makers AstraZeneca and Sanofi in recent months to ensure there is enough supply early in the season after unanticipated demand ...

3. • 

     Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

     Zacks via Yahoo Finance· 9 hours ago

     Data from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...

4. • 

     Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag

     Zacks via Yahoo Finance· 2 days ago

     The FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...

5. • 

     FDA accepts Sanofi’s Sarclisa sBLA for priority review

     Pharmaceutical Technology via Yahoo Finance· 2 days ago

     The US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...

6. • 

     J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

     Zacks via Yahoo Finance· 13 hours ago

     J&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...

7. • PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)

     ETF DAILY NEWS· 5 days ago

     PNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...

8. • 

     Sanofi reports positive data from Phase II asthma treatment trial

     Clinical Trials Arena via Yahoo Finance· 7 days ago

     Sanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...

9. • Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

     WTRF Wheeling· 5 days ago

     Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company's stockholders approved the sale to Sanofi

10. • 

      The state's largest life science employer will cut over 600 jobs - Boston Business Journal

      The Business Journals· 1 day ago

      Just a few weeks after announcing it planned to kick off a “significant, multiyear efficiency...